Skip to main content

Table 1 Patient demographics

From: Experiences of patients with cancer at health care facilities in Japan: results from a nationwide survey

  

All

% (correcteda)

Rare cancer (Group A)

% (correcteda)

Younger (Group B)

% (correcteda)

Non-rare cancer age ≥ 40 (Group C)

% (correcteda)

N

 

7080

11.3 (5.0)

797

11.3 (5.0)

709

10.0 (2.4)

5574

78.7 (92.6)

Sex

Male

3688

52.1 (53.3)

477

59.8 (59.9)

128

18.1 (16.6)

3083

55.3 (53.9)

Female

3368

47.6 (46.2)

318

39.9 (40.0)

581

81.9 (83.4)

2469

44.3 (45.6)

No response

24

0.3 (0.5)

2

0.3 (0.1)

0

0.0

22

0.4 (0.6)

Ageb

Average (SD)

66.4 (15.3)

69.4 (12.3)

65.8 (15.6)

66.2 (22.6)

36.9 (4.6)

36.8 (9.2)

70.6 (11.1)

70.5 (10.1)

 

Median (IQR)

70 (58,77)

71 (63,78)

69 (56,77)

68 (58,77)

38 (35,40)

38 (35,40)

71 (64,78)

71 (64,78)

Respondent

Patient

5583

78.9 (78.4)

576

72.3 (70.6)

667

94.1 (92.8)

4340

77.9 (78.5)

Family

1449

20.5 (20.9)

215

27.0 (27.3)

41

5.8 (7.2)

1193

21.4 (20.9)

Other

13

0.2 (0.2)

4

0.5 (2.0)

1

0.1 (0.0)

8

0.1 (0.0)

No response

35

0.5 (0.5)

2

0.3 (0.1)

0

0.0

33

0.6 (0.6)

Self-reported stage

0

381

5.4 (5.9)

33

4.1 (3.7)

29

4.1 (4.7)

319

5.7 (6.0)

I

1960

27.7 (28.3)

135

16.9 (17.9)

239

33.7 (34.1)

1586

28.5 (28.7)

II

1181

16.7 (17.1)

91

11.4 (10.7)

160

22.6 (24.0)

930

16.7 (17.3)

III

899

12.7 (13.5)

90

11.3 (10.0)

65

9.2 (9.3)

744

13.3 (13.8)

IV

1099

15.5 (15.2)

162

20.3 (22.9)

61

8.6 (7.7)

876

15.7 (14.9)

Unknown

1339

18.9 (17.1)

267

33.5 (31.9)

136

19.2 (18.2)

936

16.8 (16.3)

No response

221

3.1 (2.9)

19

2.4 (3.0)

19

2.7 (2.0)

183

3.3 (3.0)

Self-reported cancer type

Breast

959

13.5 (13.7)

13

1.6 (1.6)

216

30.5 (35.2)

730

13.1 (13.8)

Colon

1023

14.4 (17.1)

35

4.4 (5.6)

55

7.8 (7.7)

933

16.7 (18.0)

Stomach

986

13.9 (16.3)

25

3.1 (6.0)

31

4.4 (7.6)

930

16.7 (17.0)

Lung

871

12.3 (13.4)

37

4.6 (5.1)

30

4.2 (3.7)

804

14.4 (14.1)

Liver

289

4.1 (4.7)

13

1.6 (1.3)

13

1.8 (1.1)

263

4.7 (5.0)

Prostate

737

10.4 (11.0)

19

2.4 (3.3)

13

1.8 (1.1)

718

12.9 (11.7)

Cervix, Uterus

414

5.8 (4.6)

27

3.4 (3.1)

122

17.2 (14.0)

265

4.8 (4.5)

Ovary

151

2.1 (2.0)

6

0.8 (0.4)

29

4.1 (2.5)

116

2.1 (2.0)

Esophagus

227

3.2 (3.7)

8

1.0 (2.3)

4

0.6 (0.4)

215

3.9 (3.8)

Spleen

177

2.5 (2.6)

1

0.1 (0.0)

3

0.4 (0.2)

173

3.1 (2.8)

Oral

382

5.4 (3.7)

228

28.6 (30.6)

7

1.0 (1.2)

147

2.6 (2.4)

Thyroid

205

2.9 (2.0)

5

0.6 (0.4)

81

11.4 (8.4)

119

2.1 (1.9)

Lymphoma, leukemia

515

7.3 (6.7)

83

10.4 (8.0)

97

13.7 (13.8)

335

6.0 (6.5)

Bone, soft tissue sarcoma

100

1.4 (1.0)

58

7.3 (8.1)

4

0.6 (0.8)

38

0.7 (0.6)

Brain

102

1.4 (1.0)

54

6.8 (7.2)

3

0.4 (0.3)

45

0.8 (0.7)

Bladder

178

2.5 (2.8)

9

1.1 (1.7)

2

0.3 (0.2)

167

3.0 (2.9)

Testicle

50

0.7 (0.3)

47

5.9 (4.7)

13

1.8 (1.1)

3

0.1 (0.1)

Unknown primary

40

0.6 (0.7)

10

1.3 (1.8)

5

0.7 (0.8)

25

0.4 (0.6)

Other

645

9.1 (7.8)

218

27.4 (27.3)

28

3.9 (6.0)

399

7.2 (6.8)

No response

147

2.1 (2.0)

20

2.5 (2.4)

13

1.8 (1.1)

114

2.0 (2.0)

  1. Abbreviations: AYA Adolescent and young adult
  2. aDesign weight was developed based on the sampling method, and the weight is the inverse of the sampling fraction
  3. bAge at the time of response